Charles Schwab Investment Management Inc. boosted its stake in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 306,752 shares of the financial services provider’s stock after purchasing an additional 6,338 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.72% of Trupanion worth $14,785,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in TRUP. FMR LLC increased its holdings in Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after purchasing an additional 1,170,202 shares during the last quarter. Baillie Gifford & Co. increased its holdings in Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock valued at $33,806,000 after purchasing an additional 147,341 shares during the last quarter. Wellington Management Group LLP increased its holdings in Trupanion by 4.4% in the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock valued at $142,475,000 after purchasing an additional 142,156 shares during the last quarter. DF Dent & Co. Inc. increased its holdings in Trupanion by 27.8% in the third quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider’s stock valued at $15,443,000 after purchasing an additional 80,014 shares during the last quarter. Finally, Hosking Partners LLP increased its holdings in Trupanion by 52.5% in the fourth quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider’s stock valued at $10,253,000 after purchasing an additional 73,203 shares during the last quarter.
Insider Buying and Selling
In related news, CEO Margaret Tooth sold 2,294 shares of the stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $3,728,629.76. This trade represents a 1.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Emily Dreyer sold 14,025 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.41, for a total value of $454,550.25. Following the transaction, the senior vice president now owns 27,645 shares of the company’s stock, valued at approximately $895,974.45. The trade was a 33.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 25,984 shares of company stock worth $850,362. 5.50% of the stock is owned by corporate insiders.
Trupanion Stock Down 2.4 %
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The firm had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. On average, sell-side analysts expect that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Analyst Ratings Changes
TRUP has been the subject of several recent analyst reports. Stifel Nicolaus lowered their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Piper Sandler lowered their price target on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Trupanion has an average rating of “Moderate Buy” and an average target price of $46.60.
Get Our Latest Stock Analysis on TRUP
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- How to trade using analyst ratings
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.